Pim J van Leeuwen

5PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer diagnosisMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 19, 2022
The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography.

Hans Veerman, Maarten Donswijk, Elise Bekers

|Mar 18, 2020
Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68 Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection.

Thijs H Huits, Henk B Luiting, Henk G van der Poel

|Jan 21, 2020
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.

Amer Amin, Alexandar Blazevski, James Thompson

|Jul 10, 2019
Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.

Matthijs J Scheltema, John I Chang, Phillip D Stricker

|Feb 17, 2017
A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.

Pim J van Leeuwen, Andrew Hayen, James E Thompson

Pageof 1

Frequent Collaborators

3 joint publications

Phillip Stricker

2 joint publications

Matthijs J Scheltema

2 joint publications

Henk G van der Poel

1 joint publications

Francis Ting